<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24902" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Medullary Breast Carcinoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mlika</surname>
            <given-names>Mouna</given-names>
          </name>
          <aff>University of Medicine of Tunis</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mouna Mlika declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24902.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Medullary breast carcinoma is a rare and distinct subgroup of breast carcinomas. Despite its highly malignant characteristics, it has a favorable prognosis compared with the more common infiltrating ductal breast carcinoma. This activity describes the evaluation and treatment of medullary breast carcinoma and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of medullary breast carcinoma.</p></list-item><list-item><p>Assess&#x000a0;the appropriate evaluation of medullary breast carcinoma.</p></list-item><list-item><p>Evaluate the treatment and management options available for medullary breast carcinoma.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care coordination to advance the diagnosis of medullary breast carcinoma and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24902&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24902">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24902.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Medullary carcinoma is a rare and distinct subgroup of breast carcinomas&#x000a0;accounting for&#x000a0;less than 5% of all invasive breast cancers.<xref ref-type="bibr" rid="article-24902.r1">[1]</xref>&#x000a0;This unique histologic subtype has very strict criteria for diagnosis, including complete circumscription, the syncytial growth pattern of at least 75% of the tumor, intermediate to high nuclear grade, an associated diffuse lymphocytic infiltrate, and a lack of intraductal components or glandular differentiation.<xref ref-type="bibr" rid="article-24902.r2">[2]</xref>&#x000a0;The 2012 World Health Organization (WHO) updated&#x000a0;the classification of medullary carcinoma under the umbrella term &#x0201c;carcinomas with medullary features,&#x0201d; including atypical medullary carcinoma and invasive carcinoma of no special type with medullary features.<xref ref-type="bibr" rid="article-24902.r2">[2]</xref>&#x000a0;Medullary carcinoma has a favorable prognosis despite its poorly differentiated histologic features and basal-like phenotype.</p>
      </sec>
      <sec id="article-24902.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>It has been well established that both medullary and invasive ductal carcinoma with medullary features are associated with germline mutations in the BRCA1 gene. Among BRCA1-associated breast cancers, 7.8% to 19% are medullary carcinomas, and 35% to 60% show the presence of medullary features. This rate contrasts with only 2% of medullary carcinomas among sporadic, non-BRCA-associated tumors.<xref ref-type="bibr" rid="article-24902.r3">[3]</xref>&#x000a0;Medullary carcinoma has been shown to display the basal-like molecular subtype by gene expression profiling, which correlates with its immunophenotypic profile.<xref ref-type="bibr" rid="article-24902.r4">[4]</xref> A high incidence of TP53 gene mutation also presents in these tumors. Most cases are aneuploid with a high S-phase fraction.<xref ref-type="bibr" rid="article-24902.r5">[5]</xref> Array-based comparative genomic hybridization analysis has demonstrated a recurrent pattern of chromosomal alterations in medullary carcinoma, including 1q, 8q, 9p, 10p, and 16q gains; 4p and X losses; and 1q, 8p, 10p, and 12p amplicons.<xref ref-type="bibr" rid="article-24902.r6">[6]</xref></p>
      </sec>
      <sec id="article-24902.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The patient&#x02019;s age at presentation is younger than that for invasive ductal carcinoma NOS, with a mean age ranging from 45 to 54 years.<xref ref-type="bibr" rid="article-24902.r7">[7]</xref>&#x000a0;Medullary carcinoma is unicentric in most of the patients, and bilateral carcinomas have presented in an incidence ranging from 3% to 18% of patients.<xref ref-type="bibr" rid="article-24902.r7">[7]</xref>&#x000a0;Bilateral tumors are common when a family history is present.<xref ref-type="bibr" rid="article-24902.r8">[8]</xref>&#x000a0;Typical medullary breast carcinoma occurs more frequently in patients with mutations of the suppressor gene BRCA-1 present.<xref ref-type="bibr" rid="article-24902.r9">[9]</xref></p>
      </sec>
      <sec id="article-24902.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Medullary carcinoma has been shown to contain an increased number of activated cytotoxic lymphocytes, and most of the lymphoid infiltrate consists of T cells. This feature reflects an active host response to the tumor and may account for its favorable prognosis.<xref ref-type="bibr" rid="article-24902.r9">[9]</xref></p>
      </sec>
      <sec id="article-24902.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Macroscopy:</bold>
</p>
        <p>Medullary carcinoma is well-circumscribed and moderately firm. The cut surface is fleshy and gray-tan and may appear lobular or nodular. Foci of hemorrhage, necrosis, and even cystic degeneration are not unusual. These tumors tend to be smaller than 3 cm, with a median size of 2 to 3 cm.&#x000a0;</p>
        <p>
<bold>Histopathology:</bold>
</p>
        <p>The histologic criteria for medullary carcinoma were first clearly defined by Ridolfi and associates in 1977&#x000a0;<xref ref-type="bibr" rid="article-24902.r10">[10]</xref>, and since then,&#x000a0;several proposed modified classification schemes have been proposed.<xref ref-type="bibr" rid="article-24902.r11">[11]</xref>&#x000a0;The diagnosis of medullary carcinoma is established based on H&#x00026;E sections using histologic criteria in the majority of cases&#x000a0;without the need for ancillary studies. Medullary carcinoma should meet all of the following&#x000a0;5 morphologic criteria as defined by the WHO<xref ref-type="bibr" rid="article-24902.r12">[12]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Syncytial growth pattern in more than 75% of the tumor</p>
          </list-item>
          <list-item>
            <p>No glandular or tubular structures, even as a minor component</p>
          </list-item>
          <list-item>
            <p>Moderate to marked diffuse lymphoplasmacytic infiltrate in the stroma</p>
          </list-item>
          <list-item>
            <p>Moderate to marked nuclear pleomorphism</p>
          </list-item>
          <list-item>
            <p>Complete histologic circumscription</p>
          </list-item>
        </list>
        <p>Mitoses are numerous, and atypical giant cells may be present. The terms ''atypical medullary carcinoma'' and ''carcinoma with medullary features'' have been proposed for tumors that do not fulfill all these criteria. 2012 WHO recommends grouping classic medullary carcinoma, atypical medullary carcinoma, and invasive carcinoma of no special type with medullary features within the category of carcinomas with medullary features.&#x000a0;</p>
        <p>
<bold>Immunoprofile:</bold>
</p>
        <p>Medullary carcinomas are most often negative for estrogen and progesterone receptors and HER2 and variably express keratins 5/6 and 14, smooth muscle actin, EGFR, P-cadherin, p53, and caveolin-1. They have a high Ki-67 proliferation index.<xref ref-type="bibr" rid="article-24902.r9">[9]</xref><xref ref-type="bibr" rid="article-24902.r4">[4]</xref><xref ref-type="bibr" rid="article-24902.r13">[13]</xref>&#x000a0;P53 mutation occurs at an increased level in medullary carcinoma and is considered a biological marker for this tumor type.<xref ref-type="bibr" rid="article-24902.r14">[14]</xref> The lymphoid infiltrate shows a predominance of CD3+ T-lymphocytes.<xref ref-type="bibr" rid="article-24902.r4">[4]</xref></p>
      </sec>
      <sec id="article-24902.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most patients with medullary carcinoma present with a palpable mass, usually in the upper outer quadrant. The tumor is often well-defined clinically and in imaging studies. Some patients with this tumor type exhibit axillary lymphadenopathy at the time of presentation, suggesting the presence of metastatic disease.<xref ref-type="bibr" rid="article-24902.r15">[15]</xref></p>
      </sec>
      <sec id="article-24902.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>By mammography, medullary carcinoma manifests as a mass with rounded, oval, or lobulated contours. The mass is noncalcified and has a well-defined tumor border.<xref ref-type="bibr" rid="article-24902.r16">[16]</xref>&#x000a0;Similar findings appear on ultrasound examination, where examples show a well-circumscribed hypoechoic mass.<xref ref-type="bibr" rid="article-24902.r16">[16]</xref>&#x000a0;MRI studies show round, oval, or lobular mass with a smooth margin. Internal enhancement can be homogeneous or heterogeneous with delayed peripheral enhancement by contrast-enhanced MRI.<xref ref-type="bibr" rid="article-24902.r17">[17]</xref><xref ref-type="bibr" rid="article-24902.r18">[18]</xref><xref ref-type="bibr" rid="article-24902.r19">[19]</xref> Although these MRI features present consistently, they are not specific for medullary carcinoma and can be found in other histologic types of breast cancers as well as in benign lesions.<xref ref-type="bibr" rid="article-24902.r17">[17]</xref><xref ref-type="bibr" rid="article-24902.r18">[18]</xref></p>
      </sec>
      <sec id="article-24902.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment for medullary carcinoma, either typical or atypical, is similar to invasive ductal carcinoma. The division into typical and atypical subtypes does not modify treatment options and has only prognostic significance. The treatment of medullary breast carcinoma includes modified or radical mastectomy along with radiation or chemotherapy, depending on the stage.<xref ref-type="bibr" rid="article-24902.r20">[20]</xref>&#x000a0;Medullary carcinomas are sensitive to radiation and chemotherapy. Breast-conserving surgery followed by adjuvant radiation may be appropriate for tumors that are 3 cm or smaller. Indications for chemotherapy include larger tumor size, nodal metastasis, and lymphovascular invasion.</p>
      </sec>
      <sec id="article-24902.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for medullary breast carcinoma is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Invasive carcinoma of no special type</p>
          </list-item>
          <list-item>
            <p>Chronic inflammation</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Lymphoepithelioma-like carcinoma</p>
          </list-item>
          <list-item>
            <p>Melanoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24902.s11" sec-type="Staging">
        <title>Staging</title>
        <p>The most widely used clinical staging system for medullary breast carcinoma is the&#x000a0;1 adopted by the International Union for Cancer Control and the American Joint Commission on Cancer. It is based on the TNM system (T, tumor; N, nodes; M, metastases).</p>
      </sec>
      <sec id="article-24902.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Despite its histopathologically highly malignant characteristics, medullary breast carcinoma carries a favorable prognosis compared with the more common infiltrating ductal breast carcinoma. Medullary carcinoma is a biologically distinct cancer in which prognostic factors valid for other types of breast cancer appear to have less impact. Nodal status and tumor size remain the&#x000a0;2 most important prognostic factors in medullary carcinoma. There is a postulate that the extensive presence of plasma cells and lymphocytes prevents it from growing and spreading quickly.<xref ref-type="bibr" rid="article-24902.r21">[21]</xref> The overall 10-year survival rate is 74% and over 90% in patients with negative lymph nodes.<xref ref-type="bibr" rid="article-24902.r15">[15]</xref> Pure medullary carcinoma has a better prognosis than atypical features. Hence, strict adherence to diagnostic criteria is critical to provide a more accurate prognosis. Several studies have documented lymph nodal involvement to decrease overall survival significantly.<xref ref-type="bibr" rid="article-24902.r22">[22]</xref> Also, the size of the tumor and distant metastasis affect overall survival.<xref ref-type="bibr" rid="article-24902.r23">[23]</xref></p>
      </sec>
      <sec id="article-24902.s13" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Axillary lymph node metastases:</bold>
</p>
        <p>Most published studies have reported a lower incidence of axillary lymph node involvement in patients with medullary carcinoma (19% to 46%) than those with atypical medullary carcinomas (30% to 52%) or invasive ductal carcinomas (29% to 65%).<xref ref-type="bibr" rid="article-24902.r24">[24]</xref><xref ref-type="bibr" rid="article-24902.r25">[25]</xref><xref ref-type="bibr" rid="article-24902.r8">[8]</xref><xref ref-type="bibr" rid="article-24902.r26">[26]</xref> Some authors have shown that patients with medullary carcinoma of the breast with positive lymph nodes have a 10-year overall survival lower than those with N0 nodal disease (58.8% versus 97.1%).<xref ref-type="bibr" rid="article-24902.r23">[23]</xref></p>
      </sec>
      <sec id="article-24902.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations that are typically requested for patients with medullary breast carcinoma include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical oncologist</p>
          </list-item>
          <list-item>
            <p>Oncologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24902.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients must be instructed to perform breast self-examination regularly and consult their doctors if they detect any abnormality.</p>
      </sec>
      <sec id="article-24902.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Medullary breast carcinoma is a rare subtype of triple-negative breast cancer that has distinctive clinical, morphological, and molecular features. Management of medullary breast carcinoma needs an interprofessional team involving a surgical oncologist, an oncologist, a pathologist, and a radiologist. After the treatment of medullary breast carcinoma, long-term&#x000a0;follow-up is necessary to detect local and distant relapse.&#x000a0;The primary care provider must refer patients with suspected breast masses to a radiologist for further workup. Medullary breast carcinoma requires an interprofessional team approach, including primary care providers, specialists, specialty-trained nurses, and pharmacists, collaborating across disciplines to achieve optimal patient results. Breast care nurses assist in evaluation, patient education, and documentation for the team. Oncology nurses administer treatments, monitor patients, and report changes to the team. Oncologic pharmacists collaborate with oncologists, reviewing the dose and drug interactions and educating patients about compliance and side effects.</p>
      </sec>
      <sec id="article-24902.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24902&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24902">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/medullary-breast-carcinoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24902">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24902/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24902">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24902.s18">
        <title>References</title>
        <ref id="article-24902.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foulkes</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Reis-Filho</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Triple-negative breast cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Nov</month>
            <day>11</day>
            <volume>363</volume>
            <issue>20</issue>
            <fpage>1938</fpage>
            <page-range>1938-48</page-range>
            <pub-id pub-id-type="pmid">21067385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>e111493</fpage>
            <pub-id pub-id-type="pmid">25375803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <article-title>Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.</article-title>
            <source>Lancet</source>
            <year>1997</year>
            <month>May</month>
            <day>24</day>
            <volume>349</volume>
            <issue>9064</issue>
            <fpage>1505</fpage>
            <page-range>1505-10</page-range>
            <pub-id pub-id-type="pmid">9167459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weigelt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Horlings</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kreike</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hauptmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wessels</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Van de Vijver</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Van't Veer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Peterse</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Refinement of breast cancer classification by molecular characterization of histological special types.</article-title>
            <source>J Pathol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>216</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-50</page-range>
            <pub-id pub-id-type="pmid">18720457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedersen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Lykkesfeldt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Holck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schi&#x000f8;dt</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.</article-title>
            <source>Breast Cancer Res Treat</source>
            <year>1994</year>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-306</page-range>
            <pub-id pub-id-type="pmid">8049463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent-Salomon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gruel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lucchesi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>MacGrogan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dendale</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sigal-Zafrani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Longy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raynal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pierron</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Mascarel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Taris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stoppa-Lyonnet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pierga</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sastre-Garau</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Fourquet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delattre</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>de Cremoux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aurias</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.</article-title>
            <source>Breast Cancer Res</source>
            <year>2007</year>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>R24</fpage>
            <pub-id pub-id-type="pmid">17417968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foschini</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Eusebi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Rare (new) entities of the breast and medullary carcinoma.</article-title>
            <source>Pathology</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-56</page-range>
            <pub-id pub-id-type="pmid">19089740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ridolfi</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Port</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kinne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mik&#x000e9;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.</article-title>
            <source>Cancer</source>
            <year>1977</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>1365</fpage>
            <page-range>1365-85</page-range>
            <pub-id pub-id-type="pmid">907958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacquemier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Padovani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rabayrol</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lakhani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Penault-Llorca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Denoux</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fiche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Figueiro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maisongrosse</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ledoussal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Martinez Penuela</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Udvarhely</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>El Makdissi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ginestier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Geneix</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Charafe-Jauffret</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xerri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eisinger</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Birnbaum</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sobol</surname>
                <given-names>H</given-names>
              </name>
              <collab>European Working Group for Breast Screening Pathology</collab>
              <collab>Breast Cancer Linkage Consortium</collab>
            </person-group>
            <article-title>Typical medullary breast carcinomas have a basal/myoepithelial phenotype.</article-title>
            <source>J Pathol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>207</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-8</page-range>
            <pub-id pub-id-type="pmid">16167361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vu-Nishino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tavassoli</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Ahrens</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Haffty</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2005</year>
            <month>Jul</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>1040</fpage>
            <page-range>1040-7</page-range>
            <pub-id pub-id-type="pmid">15990007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedersen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Holck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mouridsen</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Sch&#x000f8;dt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zedeler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Prognostic comparison of three classifications for medullary carcinoma of the breast.</article-title>
            <source>Histopathology</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-8</page-range>
            <pub-id pub-id-type="pmid">10064398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleer</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>133</volume>
            <issue>11</issue>
            <fpage>1822</fpage>
            <page-range>1822-5</page-range>
            <pub-id pub-id-type="pmid">19886718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matkovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Juretic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Separovic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Novosel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Separovic</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gamulin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kruslin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.</article-title>
            <source>Tumori</source>
            <year>2008</year>
            <season>Nov-Dec</season>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>838</fpage>
            <page-range>838-44</page-range>
            <pub-id pub-id-type="pmid">19267102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandyopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bluth</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Ali-Fehmi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Breast Carcinoma: Updates in Molecular Profiling 2018.</article-title>
            <source>Clin Lab Med</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>401</fpage>
            <page-range>401-420</page-range>
            <pub-id pub-id-type="pmid">29776638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khomsi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ben Bachouche</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bouzaiene</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chargui</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ben Hassouna</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mtaalah</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Dhiab</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hechiche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Boussen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gamoudi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rahal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Typical medullary carcinoma of the breast: a retrospective study about 33 cases].</article-title>
            <source>Gynecol Obstet Fertil</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>1117</fpage>
            <page-range>1117-22</page-range>
            <pub-id pub-id-type="pmid">17977045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lindfors</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Lipman</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Stomper</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Genest</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast: mammographic and US appearance.</article-title>
            <source>Radiology</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>170</volume>
            <issue>1 Pt 1</issue>
            <fpage>79</fpage>
            <page-range>79-82</page-range>
            <pub-id pub-id-type="pmid">2642350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Yong</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?</article-title>
            <source>Radiographics</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1689</fpage>
            <page-range>1689-702</page-range>
            <pub-id pub-id-type="pmid">21071383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tominaga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>MR imaging of medullary carcinoma of the breast.</article-title>
            <source>Eur J Radiol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>525</fpage>
            <page-range>525-9</page-range>
            <pub-id pub-id-type="pmid">18353587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast: MRI findings.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2012</year>
            <month>May</month>
            <volume>198</volume>
            <issue>5</issue>
            <fpage>W482</fpage>
            <page-range>W482-7</page-range>
            <pub-id pub-id-type="pmid">22528930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eichhorn</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma, provocative now as then.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-73</page-range>
            <pub-id pub-id-type="pmid">15074561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tamaru</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ohnisi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Itoyama</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.</article-title>
            <source>Virchows Arch</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>446</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-4</page-range>
            <pub-id pub-id-type="pmid">15660281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Beal</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Canter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Khatri</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Bold</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast: a population-based perspective.</article-title>
            <source>Med Oncol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>738</fpage>
            <page-range>738-44</page-range>
            <pub-id pub-id-type="pmid">20390465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reinfuss</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stelmach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rys</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.</article-title>
            <source>J Surg Oncol</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-94</page-range>
            <pub-id pub-id-type="pmid">7564387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wargotz</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Silverberg</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.</article-title>
            <source>Hum Pathol</source>
            <year>1988</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>1340</fpage>
            <page-range>1340-6</page-range>
            <pub-id pub-id-type="pmid">2846422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rapin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Contesso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mouriesse</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bertin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Piekarski</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Travagli</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gadenne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.</article-title>
            <source>Cancer</source>
            <year>1988</year>
            <month>Jun</month>
            <day>15</day>
            <volume>61</volume>
            <issue>12</issue>
            <fpage>2503</fpage>
            <page-range>2503-10</page-range>
            <pub-id pub-id-type="pmid">2835145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24902.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedersen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zedeler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Holck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schi&#x000f8;dt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mouridsen</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.</article-title>
            <source>Eur J Cancer</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>31A</volume>
            <issue>13-14</issue>
            <fpage>2289</fpage>
            <page-range>2289-95</page-range>
            <pub-id pub-id-type="pmid">8652258</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
